论文信息 - Clinical evaluation of biosynthetic glucagon treatment for recovery from hypoglycemia developed in diabetic patients. The GL-G Hypoglycemia Study Group. - 字舞流文

Clinical evaluation of biosynthetic glucagon treatment for recovery from hypoglycemia developed in diabetic patients. The GL-G Hypoglycemia Study Group.

T. Hanafusa | M. Namba | S. Tarui | N. Kono

[1] E. Scolnick,et al. Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant DNA. , 1984, JAMA.

[2] L. Thim,et al. The secretion of glucagon by transformed yeast strains , 1987, FEBS letters.

[3] O. Behrens,et al. The Amino Acid Sequence of Glucagon , 1956, Diabetes.

[4] T. Ohmura,et al. [Study on recombinant hepatitis B vaccine: development of ELISA methods for detection of contaminating yeast components in the vaccine and humoral anti-yeast component antibody developed in humans and guinea-pigs]. , 1988, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[5] I. Mühlhauser,et al. Pharmacokinetics and Bioavailability of Injected Glucagon: Differences Between Intramuscular, Subcutaneous, and Intravenous Administration , 1985, Diabetes Care.

[6] B. V. Kumar,et al. Cross-reacting human and rabbit antibodies to antigens of Histoplasma capsulatum, Candida albicans, and Saccharomyces cerevisiae , 1985, Infection and immunity.